Brain Trust: Conversations in Psychopharmacology

Experts explain how careful pediatric psychopharmacology and early intervention protect development, curb relapse, and address substance-use risk.

Expert psychiatrists share new ASCP deprescribing guidance, tackling overprescribing, primary-care challenges, and practical tapering strategies to improve safer, patient-centered mental health care.

Explore psychopharmacologic options for personality disorders in this podcast.

Psychiatry leaders unpack pharmacogenetic testing hype, spotlight 4 actionable genes, and urge evidence-based use with therapeutic drug monitoring for personalized treatment.

Experts discuss rapid cycling and bipolar II, and weigh lithium as an often overlooked treatment option.

Psilocybin therapy shows fast, lasting relief for depression; clinicians discuss trial hurdles and emerging promise for PTSD and addiction in this podcast.

Learn when CBT/IPT beats medications, when to combine antidepressants, and why patient preference drives depression recovery in 6–12 weeks in this podcast.

Explore GLP-1 agonists and their "truly transformative" role in psychiatry in this podcast.

Learn more about the treatment of depression, selective serotonin reuptake inhibitors, and pregnancy in this podcast.

Psychiatry experts unpack why off-label medications are common and how evidence and dosing guide care.

Experts discuss why early treatment and tailored combos can curb bipolar disorder.

Experts unpack child psychiatric medication: safety, early intervention, suicide risk, and managing side effects.

Explore the complexities of psychopharmacology in treating personality disorders, focusing on symptom management and the importance of therapeutic alliances.

Explore the complexities of pharmacogenetic testing in psychiatry, uncovering its current limitations and future potential in personalized medicine.

Learn more about the transformative potential of psychedelics in treating depression and mood disorders through expert insights and groundbreaking research.

Explore the intersection of psychotherapy and pharmacology in treating mood disorders, emphasizing personalized approaches for optimal patient outcomes.

What is the role of GLP-1 agonists in psychiatry? Joseph F. Goldberg, MD, and Roger S. McIntyre, MD, FRCPC, share their thoughts.

In his brand new video series, Joseph F. Goldberg, MD, sits down with Marlene Freeman, MD, to discuss the issue of SSRIs and pregnancy.